Treatment of helminth co-infection in individuals with HIV-1: A systematic review of the literature

PLoS Neglected Tropical Diseases

Volumn 1, Issue 3, 2007, Pages

  Walson, Judd L ^a   John Stewart, Grace ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; MEBENDAZOLE; PRAZIQUANTEL; VIRUS RNA; ANTHELMINTIC AGENT;

CD4 LYMPHOCYTE COUNT; CLINICAL PROTOCOL; CLINICAL TRIAL; COCHRANE LIBRARY; DATA BASE; DISEASE COURSE; EMBASE; ERADICATION THERAPY; FOLLOW UP; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MEDLINE; MORTALITY; NONHUMAN; REVIEW; SCHISTOSOMIASIS; SINGLE DRUG DOSE; STAGING; SUPERINFECTION; SYSTEMATIC REVIEW; COHORT ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PARASITOLOGY; VIROLOGY; VIRUS LOAD;

ANTHELMINTICS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; HELMINTHIASIS; HIV INFECTIONS; HIV-1; HUMANS; VIRAL LOAD;

EID: 43949127129     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000102     Document Type: Review

References (34)

1. Lawn SD, Karanja DM, Mwinzia P, Andove J, Colley DG, et al. (2000) The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. Aids 14: 2437-2443.
2. Wolday D, Mayaan S, Mariam ZG, Berhe N, Seboxa T, et al. (2002) Treatment of intestinal worms is associated with decreased HIV plasma viral load. J Acquir Immune Defic Syndr 31: 56-62.
3. Eggena MP, Barugahare B, Okello M, Mutyala S, et al. (2005) T cell activation in HIV-seropositive Ugandans: Differential associations with viral load, CD4+ T cell depletion, and coinfection. JID 191: 694-701.
4. (2004) UNAIDS 2004 Report on the Global AIDS Epidemic-Executive Summary.
5. Fincham JE, Markus MB, Adams VJ (2003) Could control of soil-transmitted helminthic infection influence the HIV/AIDS pandemic. Acta Trop 86: 315-333.
6. Bentwich Z, Weisman Z, Moroz C, Bar-Yehuda S, Kalinkovich A (1996) Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections? Clin Exp Immunol 103: 239-243.
7. Kassu A, Tsegaye A, Wolday D, Pares B, Aklilu M, et al. (2003) Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clin Exp Immunol 132: 113-119.
8. Brown M, Mawa PA, Kaleebu P, Elliott AM (2006) Helminths and HIV infection: epidemiological observations on immunological hypotheses. Parasite Immunol 28: 613-623.
9. Borkow G, Bentwich Z (2006) HIV and helminth co-infiection: is deworming necessary? Parasite Immunol 28: 605-612.
10. Shapira-Nahor O, Kalinkovich A, Weisman Z, Greenberg Z, Nahmias J, et al. (1998) Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals. Aids 12: 1731-1733.
11. Kallestrup P, Zinyama R, Gorno E, Butterworth AE, Mudenge B, et al. (2005) Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. J Infect Dis 192: 1956-1961.
12. Bentwich Z, Kalinkovich A, Weisman Z (1995) Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 16: 187-191.
13. Brown M, Kizza M, Watera C, Quigley MA, Rowland S, et al. (2004) Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. J Infect Dis 190: 1869-1879.
14. Elliott AM, Mawa PA, Joseph S, Namujju PB, Kizza M, et al. (2003) Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults. Trans R Soc Trop Med Hyg 97: 103-108.
15. Modjarrad K, Zulu I, Redden DT, Njobvu L, Lane HC, et al. (2005) Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults. J Infect Dis 192: 1277-1283.
16. Gupta SB, Jacobson LP, Margolick JB, Rinaldo CR, Phair JP, et al. (2007) Estimating the benefit of an HIV-1 vaccine that reduces viral load set point. J Infect Dis 195: 546 550.
17. Walson JL, John-Stewart G (2007) Treatment of helminth co-infection in HIV-1 infected individuals in resource limited settings, protocol. The Cochrane Library [database on CDROM].
18. Kelly P, Lungu F, Keane E, Baggaley R, Kazembe F, Pobee J, et al. (1996) Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomized double blind controlled trial. British Medical Journal 312: 1187.
19. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Loses M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Department of Epidemiology and Community Medicine, University of Ottawa, Canada.
20. Gallagher M, Malhotra I, Mungai PL, Wamachi AN, Kioko JM, et al. (2005) The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. Aids 19: 1849-1855.
21. Ganley-Leal IM, Mwinzi PN, Cetre-Sossah CB, Andove J, Hightower AW, et al. (2006) Correlation between eosnophils and protection against reinfection with schistosoma mansoni and the effect of human immunodeficiency virus type I coinfection in humans. Infection and Immunity 74: 2169-2176.
22. Hosseinipour MC, Napravnik S, Joaki G, Gama S, Mbeye N, et al. (2007) HIV and Parasitic Infection and the Effect of Treatment among Adult Outpatients in Malawi. J Infect Dis 195: 1278-1282.
23. Kallestrup, P, Zinyama R, Gomo, E, Butterworth AE, van Dam GJ, et al. (2006) Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection. Clinical Infectious Diseases 42: 1781-1789.
24. McElroy MD, Elrefaei M, Jones N, Ssali F, Mugyenyi P, et al. (2005) Coinfection with schistosoma mansoni is associated with decreased HIV-specific cytolysis and increased IL-10 production. The Journal of Immunology 174: 5119-5123.
25. Mwanakasale V, Vounatsou P, Sukwa TY, Ziba M, Ernest A, et al. (2003) Interactions between schistosoma haematobium and human immunodeficiency virus type 1: The effects of coinfection on treatment outcomes in rural Zambia. American Journal of Tropical Medicine and Hygiene 69: 420-428.
26. Brown M, Mawa PA, Joseph S, Bukusuba J, Watera C, et al. (2005) Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults. J Infect Dis 191: 1648-1657.
27. JPT H (2005) Effect measures for continuous outcomes. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Library.
28. Allen JE, Lawrence RA, Maizels RM (1996) APC from mice harbouring the filarial nematode, Brugia malayi, prevent cellular proliferation but not cytokine production. Int Immunol 8: 143-151.
29. Maizels RM, Yazdanbakhsh M (2003) Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 3: 733-744.
30. Actor JK, Shirai M, Kullberg MC, Buller RM, Sher A, et al. (1993) Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci U S A 90: 948-952.
31. Gomez-Escobar N, Gregory WF, Maizels RM (2000) Identification of tgh-2, a filarial nematode homolog of Caenorhabditis elegans daf-7 and human transforming growth factor beta, expressed in microfilarial and adult stages of Brugia malayi. Infect Immun 68: 6402-6410.
32. Goodridge HS, Wilson EH, Harnett W, Campbell CC, Harnett MM, et al. (2001) Modulation of macrophage cytokine production by ES-62, a secreted product of the filarial nematode Acanthocheilonema. viteae. J Immumol 167: 940-945.
33. Pastrana DV, Raghavan N, FitzGerald P, Eisinger SW, Metz C, et al. (1998) Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect Immun 66: 5955-5963.
34. van der Kleij D, Latz E, Brouwers JF, Kruize YC, Schmitz M, et al. (2002) A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 277: 48122-48129.